Tenpoint Therapeutics Ltd. Announces FDA Approval of YUVEZZI™, the First and Only Combination Eye Drop Approved to Treat Presbyopia

YUVEZZI (carbachol and brimonidine tartrate ophthalmic solution) 2.75%/0.1% is the only dual-agent presbyopia-correcting eye drop intentionally designed to deliver durability, tolerability, and safety YUVEZZI was studied in two pivotal Phase 3 trials enrolling more than 800 patients, including the world’s largest and longest safety study for presbyopia eye drops1,2 YUVEZZI achieves miosis from 30-minutes up … [Read more…]

Neogen Issues Voluntary Nationwide Recall of Neogen®Vet HYCOAT® Hyaluronate Sodium Sterile Solution

LANSING, Mich.–(BUSINESS WIRE)–Neogen Corporation (NASDAQ: NEOG) is voluntarily recalling all lots within expiry of Neogen®Vet HYCOAT® Hyaluronate Sodium Sterile Solution, for use in dogs, cats, and horses, to the veterinarian level. Neogen distributes this product, which is manufactured by a third-party supplier. This recall has been initiated due to microbial contamination in certain lots of … [Read more…]

Personalis to Participate in the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference

FREMONT, Calif.–(BUSINESS WIRE)–Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, announced today that its management team will be attending the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference on Wednesday, February 11, 2026 at the Cliff Lodge in Snowbird, UT. About Personalis, Inc. At Personalis, we are … [Read more…]

Caduceus Capital Partners and Scottsdale Institute Announce Collaborative Partnership

NASHVILLE, Tenn.–(BUSINESS WIRE)–#digitalhealth–Today, venture capital firm Caduceus Capital Partners and the Scottsdale Institute announced that they have entered a collaborative partnership to achieve their shared goal of accelerating the transformation of healthcare delivery through strategic innovation. Scottsdale Institute, a premier membership organization of health system leaders, works to leverage information technology, operating models, and strategy … [Read more…]

Intelas Launches TeamCHAMPS, Its New Mobile Application for HTM for Fast, Trackable Service Requests

New mobile experience is part of Intelas’ TechCONNECT mobile experience, connecting technicians, clinical staff, and hospital leaders on a single platform, helping accelerate issue resolution and improve real-time visibility across medical equipment service MOORESVILLE, N.C.–(BUSINESS WIRE)–Intelas, Compass Healthcare’s signature Healthcare Technology Management (HTM) brand, has launched TeamCHAMPS, a new mobile experience designed to simplify medical … [Read more…]

Shorla Oncology® Announces U.S. FDA Approval of Larger Vial Size for Nelarabine Intravenous Administration for the Treatment of T-cell Acute Lymphoblastic Leukemia and T-cell Lymphoblastic Lymphoma

New 375mg vial addresses critical dosing gap for adult and pediatric patients living with T-cell Acute Lymphoblastic Leukemia and T-cell Lymphoblastic Lymphoma CAMBRIDGE, Mass.–(BUSINESS WIRE)–Shorla Oncology (‘Shorla’), a U.S.-Ireland specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration has approved the company’s oncology drug, Nelarabine Injection, in a larger vial size, 375mg/75mL, … [Read more…]

SFI Health™ EMEA Announces the Launch in Poland of Equazen® Forte, Marking a New Chapter in Cognitive Support for Young Adults and Adults

Equazen® Forte represents a strategic evolution of the brand, extending its clinically researched omega-3 based cognitive support product formulation beyond children to young adults and adults through pharmacies across Poland. LUGANO, Switzerland–(BUSINESS WIRE)–#GLAsupplements–SFI Health™ EMEA, the regional entity of SFI Health™, a global leader in natural healthcare, today is pleased to announce the launch of … [Read more…]

United States Drug Testing Laboratories (USDTL) and CourtFact Announce Integrated Partnership to Streamline Case Management and Drug Testing Services

DES PLAINES, Ill.–(BUSINESS WIRE)–United States Drug Testing Laboratories (USDTL), a national leader in forensic and clinical toxicology and mid- to long-term drug and alcohol testing, today announced a new integration partnership with CourtFact, a trusted client management platform widely used by justice-involved programs and service providers across the country. The collaboration brings USDTL’s comprehensive lab-based … [Read more…]

Nondrug Emotion Regulation Therapy Enters Pilot Program as Federal Mental Health System Faces Major Disruption

LAS VEGAS–(BUSINESS WIRE)–#BehavioralHealth–As the U.S. mental health system faces sustained funding instability, workforce burnout, and rising demand for rapid, nonpharmaceutical support, JOYELY, LLC, an emotional regulation pilot program, is launching in California this February. The timing reflects growing strain across the mental health ecosystem. Federal agencies and community providers have faced staffing disruptions and grant … [Read more…]

Innovaccer Unveils AI Platforms as Healthcare Leaders Debate Economics, Workforce Constraints, and Administrative Burden at Xccelerate 2026

The largest autonomous healthcare conference convened 300+ leaders from over 200 organizations. SAN FRANCISCO–(BUSINESS WIRE)–Innovaccer, a leading healthcare AI company, today concluded Xccelerate 2026, its annual customer and industry conference, where healthcare executives, clinicians, policymakers, and technology leaders gathered to address a growing challenge facing the industry: how to meet rising demand for care with … [Read more…]